Clinical Trial Update: Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan

View source ↗

Summary

A clinical trial evaluating Cemivil (imatinib) for chronic myeloid leukemia in Jordan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Cemivil (imatinib)

Snippet

Sponsor: Hikma Pharmaceuticals LLC | Conditions: Chronic Myeloid Leukemia, Chronic Phase | Status: COMPLETED